• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/16

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

16 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

Anticoagulants

Inhibit/ prevent the action or formation of clots


-strokes


-myocardial infraction


-deep thrombosis


-pulmonary embolism

Anticoagulants MOA

-Varies on drug


-Does not lyse existing clots


-Works on different points of clotting cascade

Anticoagulant drugs

Heparin


Low-molecular-weight Heparin


-Enoxaparin -Dalteparin


Fondaparinux


Warfarin


6 drugs

Anticoagulant Indications: Heparin

-Monitored by activated partial thromboplastin time (aPTT)


-short half life


-effects reversed by Protamine Sulfate


-turn off coagulation pathways and prevent clot formation

Anticoagulant Indication: Warfarin

-Vitamin K administered if toxicity occurs


-monitored by prothrombin time ( PT) or INR (PT-INR)


-given orally only

Anticoagulant Drugs/Indications: LMWH

Enoxaparin


Dalteparin


-More predictable anticoagulant response


-given subcutaneously


-do not require frequent lab monitoring

Antiplatelet Drugs

Aspirin


Dipyridamole


2 drugs

Antiplatelet Drugs: APD inhibitors


Clopidogrel


Ticlopidine

2 drugs

Antiplatelet Drugs: Glycoprotein 2b/3a inhibitors

Tirofiban


Eptifibate


Abciximab

3 drugs

Antiplatelet MOA

Prevent platelet adhension

Antiplatelet: Indications

Antithrombotic effects, reduce risk of fatal and non fatal strokes, acute angina, and MI

Antifibrinolytic Drugs

Aminocaproic acid


Desmopressin


-similar to ADH


-treats diabetes insipidus

2 drugs

Antifibrinolytic Drugs: Indication

Prevent/treat excessive bleeding


-hyperfibrinolysis


-surgical complications


-excessive oozing from surgical sites, i.e chest tubes


-reduce total blood loss/duration of bleeding in postoperative period


Treatment of hemophilia or Von Willebrands disease

Thrombolytic Drugs

Streptokinase


Urokinase


Tissue plasminogen activator (t-PA)


Anisoylated plasminogen-streptokinase activator (APSAC)


Anistreplase


Alteplase


Reteplase


Tenecteplase

8 drugs

Thrombolytic Drugs MOA

-Activate fibrinolytic system to break clots down in blood vessel quickly



-Activate plasminogen, convert to plasmin which digest fibrin



- Reestablish blood flow to heart muscles via coronary arteries preventing tissue destruction

Thrombolytic Drugs: Indications

Acute MI


Arterial thrombosis


DVT


Occlusion of shunts or Catheters


PE


Acute ischemic stroke